Volume and composition of reflux after intravitreal injection

Retina

Volumn 34, Issue 7, 2014, Pages 1473-1476

  Brodie, Frank L ^a   Ruggiero, Jason ^a   Ghodasra, Devon H ^a   Hui, James Z ^b   Vanderbeek, Brian L ^a,b   Brucker, Alexander J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

intravitreal injection; reflux

Indexed keywords

HEMATOXYLIN; ACETIC ACID DERIVATIVE; BALANCED SALT SOLUTION; COLORING AGENT; DRUG COMBINATION; MINERAL; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CADAVER; CILIARY DISK; COLOR; CONJUNCTIVA DISEASE; CONTROLLED STUDY; DIGITAL IMAGING; EYE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING SYSTEM; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; SCHIRMER STRIP; SCHIRMER TEST; SUBCONJUNCTIVAL BLEB; VERY ELDERLY; VITREOUS DISEASE; VITREOUS FLUID REFLUX; BIOAVAILABILITY; DRUG COMBINATION; DRUG EFFECTS; INTRAOCULAR HYPERTENSION; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; VITREOUS BODY;

ACETATES; AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; COLORING AGENTS; DRUG COMBINATIONS; HEMATOXYLIN; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MIDDLE AGED; MINERALS; OCULAR HYPERTENSION; SODIUM CHLORIDE; TONOMETRY, OCULAR; VITREOUS BODY;

EID: 84903274471     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000098     Document Type: Article

References (14)

1. Benz MS, Albini TA, Holz ER, et al. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 2006;113: 1174-1178.
2. Boon CJF, Crama N, Klevering BJ, et al. Reflux after intravitreal injection of bevacizumab. Ophthalmology 2008;115:1270. (Pubitemid 351885413)
3. Rodrigues EB, Grumann A Jr, Penha FM, et al. Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. J Ocul Pharmacol Ther 2011;27: 197-203.
4. Christoforidis JB, Williams MM, Epitropoulos FM, Knopp MV. Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous. Clin Experiment Ophthalmol 2013;41: 614-615.
5. Brodie FL, Ruggiero J, Ghodasra DH, et al. A Novel Method for the Measurement of Reflux from Intravitreal Injections: Data from 20 Porcine Eyes. Curr Eye Res. 2013.
6. Gavet O, Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 2010;18: 533-543.
7. Burgess A, Vigneron S, Brioudes E, et al. From the cover: loss of human greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A 2010;107: 12564-12569.
8. Potapova TA, Sivakumar S, Flynn JN, et al. Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol Biol Cell 2011;22: 1191-1206.
9. Ho VY, Yeh S, Olsen TW, et al. Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors. Am J Ophthalmol 2013;156:23-28.e2.
10. Schachat AP. Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Am J Ophthalmol 2013;156:1-2.e1.
11. Bakall B, Folk JC, Boldt HC, et al. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Am J Ophthalmol 2013;156:15-22.e1.
12. Hubschman JP, Coffee RE, Bourges JL, et al. Experimental model of intravitreal injection techniques. Retina 2010;30: 167-173.
13. Locke JC, Morton WR. Further studies of the viscosity of aspirated human vitreous fluid: with special reference to its use in retinal detachment surgery. Trans Am Ophthalmol Soc 1965;63: 129-145.
14. Kawano SI, Honda Y, Negi A. Effects of biological stimuli on the viscosity of the vitreous. Acta Ophthalmol (Copenh) 1982; 60: 977-991.